The global ceftiofur market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Ceftiofur is an approved veterinary medicine to treat various disorders in beef or dairy cattle, pigs and others. It is a third-generation cephalosporin antibiotic that act as anti-bacterial activity by binding to penicillin-binding proteins (PBPs) on the bacterial cell wall and inactivating them. The pivotal factor contributing to the growth of the market includes a rise in the mortality rate among cattle and swine and around the globe with reproductive tract infections, coupled with skin and soft tissue infections. Further, a high demand for these antibiotics is majorly attributed to their approval for treatment of bacterial respiratory disease associated with various bacteria. These bacteria include Mannheimia haemolytica and Haemophilus somnu among cattle, and Actinobacillus pleuropneumoniae and Streptococcus suis infections among swine.
Get Free Sample link @ https://www.omrglobal.com/request-sample/ceftiofur-market
As per the Centers for Disease Control and Prevention (CDC) in June 2019, an estimated number of 48.8 million cases coupled with 959,000 hospitalizations were registered in the US with swine flu. Therefore, the growth in the prevalence of flu along with growth in the research activities is expected to propel the growth of the ceftiofur market. Another key factor that drives the market growth includes the growing awareness about animal health and protein-rich foods for pet animals. Further, their higher consumption across the globe is also anticipated to boost the market. According to the National Pork Board’s stats for 2018, the World Per Capita Pork Consumption shares were 40.1% of total meat consumption across the globe. Thus, increasing demand to maintain a healthy swine population is likely to increase these antibiotics’ demand.
Full report of Ceftiofur Market available @ https://www.omrglobal.com/industry-reports/ceftiofur-market
Market Coverage
- Segment Covered-
o By Drug Type
o By Animal Type
o By Application
- Regions covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape: Pfizer Inc., Zoetis Inc., and Ceva Santé Animale, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Ceftiofur Market Report by Segment
By Drug Type
- Ceftiofur Sodium
- Ceftiofur Hydrochloride
- Ceftiofur Crystalline Free Acid
By Animal Type
- Horse
- Swine
- Cattle
- Others
By Application
- Bovine Interdigital Necrobacillosis
- Respiratory Infections
- Urinary Tract Infections
- Others
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ceftiofur-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
